B-cell Hematologic Malignancies
📧 Sign up to get email alerts when something new happens for B-cell Hematologic Malignancies.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-08-13Clinical Trial Update: RN1201injection for Relapsed/Refractory CD19+/BCMA+ Hematologic Malignancies [Phase 1]
A Phase 1 clinical trial update for RN1201 injection in relapsed/refractory CD19+/BCMA+ hematologic malignancies, currently not recruiting.
-
CLINICAL_TRIALS research · 2025-06-18Clinical Trial Update: To Observe the Dual-target Chimeric Antigen Receptor T Cells in the Treatment of B Cell Hematologic Tumors [Phase 1]
Phase 1 clinical trial evaluating dual-target CAR-T cells for B-cell hematologic tumors is currently recruiting.